(PRESS RELEASE) RANCHO CORDOVA, CA and DALLAS, TX — With a focus on supporting independent optometry, VSP Global and Essilor have reached an agreement that further promotes choice for doctors and patients while bolstering a competitive marketplace for its collective stakeholders now and in the future.
With this agreement in place, VSP Global will not proceed with changes to its formulary planned for January 1, 2021. After extensive efforts from both companies in what has been a difficult year, the two organizations arrived at a solution that will allow each to further reinvest in programs and services that benefit doctors, patients, and ultimately the industry.
“By coming together in good faith and seeking common ground, we’re pleased that our organizations have established a positive path forward that benefits our shared stakeholders and the industry we both serve,” said Michelle Skinner, VSP Global chief network officer.
“Because of this agreement, doctors can focus on what is most important to them: patient care. We are all committed to investing in private practice and the choice for doctors to prescribe the lens brands they choose,” said Rick Gadd, president, Essilor North America.
